![]() Lyman Kebler in the laboratory, circa 1922. |
The Bureau of Chemistry created the independent Office of Drug Administration in the early 1920s, headed by Glover, to assist the Division of Drugs with issues specific to drug labeling. In March 1923 Glover was recalled to the USPHS and the Office was abolished. At the same time, Kebler became head of the autonomous Office of Special Collaborative Investigations, which worked on mail fraud issues with the Post Office Department, and the Division of Drugs was reorganized. |